# Ipilimumab

**Source:** https://www.startuphub.ai/startups/ipilimumab
**Profile type:** Startup

> Ipilimumab is a monoclonal antibody used in cancer immunotherapy, primarily targeting CTLA-4 to activate the immune system against cancer cells.

## About

Ipilimumab, sold under the brand name Yervoy, is a fully human monoclonal antibody that targets CTLA-4, a protein receptor that downregulates the immune system. By blocking CTLA-4, ipilimumab activates T cells, thereby enhancing the body's immune response against cancer cells. It is approved for the treatment of various cancers, including melanoma, renal cell carcinoma, and colorectal cancer, often in combination with other therapies like nivolumab.

## Key facts

- **Slug:** ipilimumab
- **Website:** https://ipilimumab.ai
- **Operating status:** Active
- **Sectors / tags:** Immunotherapy, Monoclonal Antibody, Oncology, Cancer Treatment, Biologic therapy

## Frequently asked

### What does Ipilimumab do?

Ipilimumab, sold under the brand name Yervoy, is a fully human monoclonal antibody that targets CTLA-4, a protein receptor that downregulates the immune system. By blocking CTLA-4, ipilimumab activates T cells, thereby enhancing the body's immune response against cancer cells. It is approved for the treatment of various cancers, including melanoma, renal cell carcinoma, and colorectal cancer, often in combination with other therapies like nivolumab.

### What industry does Ipilimumab operate in?

Ipilimumab operates in Immunotherapy, Monoclonal Antibody, Oncology, Cancer Treatment, Biologic therapy.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Ipilimumab",
          "item": "https://www.startuphub.ai/startups/ipilimumab"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/ipilimumab#webpage",
      "url": "https://www.startuphub.ai/startups/ipilimumab",
      "name": "Ipilimumab - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Ipilimumab. Ipilimumab is a startup operating in Immunotherapy and Monoclonal Antibody. Ipilimumab is a monoclonal antibody used in cancer immunotherapy, primarily targeting CTLA-4 to activate the immune system against cancer cells.",
      "dateModified": "2026-07-23T06:22:09.27+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/ipilimumab#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/ipilimumab#organization",
      "name": "Ipilimumab",
      "url": "https://ipilimumab.ai",
      "logo": "https://www.google.com/s2/favicons?domain=ipilimumab.ai&sz=128",
      "image": "https://www.google.com/s2/favicons?domain=ipilimumab.ai&sz=128",
      "description": "This is the official profile of Ipilimumab. Ipilimumab is a startup operating in Immunotherapy and Monoclonal Antibody. Ipilimumab is a monoclonal antibody used in cancer immunotherapy, primarily targeting CTLA-4 to activate the immune system against cancer cells.",
      "sameAs": [
        "https://www.startuphub.ai/startups/ipilimumab"
      ],
      "knowsAbout": [
        "Immunotherapy",
        "Monoclonal Antibody",
        "Oncology",
        "Cancer Treatment",
        "Biologic therapy"
      ]
    }
  ]
}
```